Chas P. Smith & Associates (CPS)’s Teva Pharmaceuticals TEVA Stock Holding History

Chas P. Smith & Associates (CPS)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-162,243	Closed	-$10.1M	–	104
2015 Q1	$10.1M	Sell	162,243 -6,016	-4%	-$350K	1.81%	26
2014 Q4	$9.68M	Sell	168,259 -11,040	-6%	-$615K	1.75%	27
2014 Q3	$9.64M	Sell	179,299 -3,013	-2%	-$160K	1.91%	26
2014 Q2	$9.56M	Sell	182,312 -630,744	-78%	-$32.2M	1.94%	27
2014 Q1	$43M	Buy	813,056 +28,895	+4%	+$1.34M	3.17%	8
2013 Q4	$31.4M	Buy	784,161 +531,074	+210%	+$20.9M	2.43%	17
2013 Q3	$9.56M	Buy	253,087 +4,603	+2%	+$180K	2.44%	19
2013 Q2	$9.74M	Buy	+248,484	New	+$9.68M	2.59%	14

Other funds holding TEVA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management

Lazard Asset Management New York $60.7B AUM 22.47% 1-Year Est. Return

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $6.69B AUM

BlackRock Advisors Wilmington, Delaware $92.2B AUM 15.8% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Allianz Asset Management

Allianz Asset Management Munich, Germany $86.6B AUM 38.74% 1-Year Est. Return

PointState Capital New York $4.31B AUM 42.31% 1-Year Est. Return